NALLI, CECILIA
 Distribuzione geografica
Continente #
NA - Nord America 778
EU - Europa 431
AS - Asia 156
AF - Africa 2
OC - Oceania 1
Totale 1.368
Nazione #
US - Stati Uniti d'America 776
PL - Polonia 98
DE - Germania 72
CN - Cina 69
IT - Italia 68
UA - Ucraina 53
HK - Hong Kong 49
FI - Finlandia 41
IE - Irlanda 26
GB - Regno Unito 25
SG - Singapore 24
FR - Francia 14
SE - Svezia 8
MK - Macedonia 7
GR - Grecia 4
VN - Vietnam 4
RU - Federazione Russa 3
BE - Belgio 2
ES - Italia 2
IN - India 2
PH - Filippine 2
SA - Arabia Saudita 2
SK - Slovacchia (Repubblica Slovacca) 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
BA - Bosnia-Erzegovina 1
CA - Canada 1
CH - Svizzera 1
CZ - Repubblica Ceca 1
IQ - Iraq 1
JM - Giamaica 1
JP - Giappone 1
NL - Olanda 1
NZ - Nuova Zelanda 1
RS - Serbia 1
TR - Turchia 1
UG - Uganda 1
ZA - Sudafrica 1
Totale 1.368
Città #
Fairfield 122
Warsaw 98
Woodbridge 69
Ashburn 61
Houston 59
Seattle 50
Hong Kong 48
Jacksonville 45
Cambridge 44
Princeton 44
New York 42
Helsinki 40
Chandler 37
Wilmington 36
Ann Arbor 27
Dublin 26
Beijing 17
Brescia 16
Shanghai 16
Singapore 13
Munich 11
Lancaster 9
Nanjing 9
Des Moines 8
San Diego 7
Hebei 6
Los Angeles 6
Milan 5
Rome 5
Romola 5
Bosio 4
Dong Ket 4
Nanchang 4
Changsha 3
Duncan 3
Skopje 3
Strasbourg 3
Brussels 2
Cosenza 2
Crotone 2
Hangzhou 2
Jiaxing 2
Khobar 2
Lanzhou 2
London 2
Manerbio 2
Motta Baluffi 2
Redwood City 2
San Francisco 2
Santa Cruz de Tenerife 2
Tianjin 2
Acton 1
Amsterdam 1
Aosta 1
Auckland 1
Augusta 1
Belgrade 1
Brno 1
Cagayan de Oro 1
Centurion 1
Changchun 1
Clearwater 1
Gunzenhausen 1
Islington 1
Jinan 1
Kilburn 1
Levice 1
Magdeburg 1
Mountain View 1
New Bedfont 1
Norwalk 1
Nürnberg 1
Redmond 1
Rivoli 1
Shenyang 1
Soncino 1
Taiyuan 1
Taizhou 1
Tokyo 1
Toronto 1
Tower Hamlets 1
Washington 1
Westminster 1
Zhengzhou 1
Totale 1.066
Nome #
Long-term outcome of children of rheumatic disease patients 171
Antirheumatic drugs and reproduction in women and men with chronic arthritis. 152
Long-term neurodevelopmental outcome of children born to prospectively followed pregnancies of women with systemic lupus erythematosus and/or antiphospholipid syndrome 105
COVID-19 in patients with rheumatic diseases in northern Italy: a single-centre observational and case–control study 102
Anti-phospholipid IgG antibodies detected by line immunoassay differentiate patients with anti-phospholipid syndrome and other autoimmune diseases 94
Long-term outcome of children born from mothers with autoimmune diseases 88
Recurrent thrombosis in patients with antiphospholipid antibodies and arterial thrombosis on antithrombotic therapy 81
Beyond thrombosis: Anti-β2GPI domain 1 antibodies identify late pregnancy morbidity in anti-phospholipid syndrome 55
Autoimmune diseases and pregnancy 51
Infertility in women with systemic autoimmune diseases 49
“Disease knowledge index” and perspectives on reproductive issues: A nationwide study on 398 women with autoimmune rheumatic diseases 48
Disease course and obstetric outcomes of pregnancies in juvenile idiopathic arthritis: are there any differences among disease subtypes? A single-centre retrospective study of prospectively followed pregnancies in a dedicated pregnancy clinic 48
Neuropsychiatric Outcome of Children Born to Women With Systemic Lupus Erythematosus and Exposed in Utero to Azathioprine: A Case-Control Study 42
Comparative study of obstetric antiphospholipid syndrome (OAPS) and non-criteria obstetric APS (NC-OAPS): Report of 1640 cases from the EUROAPS registry 35
“APS pregnancy – The offspring” 33
Long-term Outcome of Children Born to Women with Autoimmune Rheumatic Diseases: A Multicentre, Nationwide Study on 299 Randomly Selected Individuals 33
CXCL-13 serum levels in patients with rheumatoid arthritis treated with abatacept 31
The Influence of Treatment of Inflammatory Arthritis During Pregnancy on the Long-Term Children's Outcome. 30
Low Preconception Complement Levels Are Associated with Adverse Pregnancy Outcomes in a Multicenter Study of 260 Pregnancies in 197 Women with Antiphospholipid Syndrome or Carriers of Antiphospholipid Antibodies. 30
Managing puerperium in patients with systemic autoimmune diseases: an update 30
Gender differences in primary antiphospholipid syndrome with vascular manifestations in 433 patients from four European centres 28
Clinical Delphi on aPLnegativization: report from the from the APS Study Group of the Italian Society for Rheumatology (SIR-APS) 22
Stopping bDMARDs at the beginning of pregnancy is associated with disease flares and preterm delivery in women with rheumatoid arthritis 19
Management of pregnancy in autoimmune rheumatic diseases: maternal disease course, gestational and neonatal outcomes and use of medications in the prospectiveItalian P-RHEUM.it study 10
Pregnancy in antiphospholipid syndrome: what should a rheumatologist know? 8
The prevalence and incidence of thrombotic primary antiphospholipid syndrome in adults aged 18-49 years: A population-based study in a mountain community in northern Italy 5
Erratum: Clinical Delphi on aPL Negativization: Report from the APS Study Group of the Italian Society for Rheumatology (SIR-APS) 3
Damage measured by Damage Index for Antiphospholipid Syndrome (DIAPS) in antiphospholipid antibody-positive patients included in the APS ACTION registry 3
Associations Among Antiphospholipid Antibody Types, Isotypes, and Titers: An AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Study 3
Totale 1.409
Categoria #
all - tutte 10.122
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.122


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020200 0 0 10 23 15 27 23 25 22 20 22 13
2020/2021302 4 30 15 28 30 24 39 20 31 37 28 16
2021/2022211 18 37 11 10 1 14 7 13 11 22 24 43
2022/2023158 31 0 3 2 19 44 0 11 22 1 13 12
2023/2024268 18 12 27 28 9 55 10 16 49 12 3 29
2024/202537 18 11 8 0 0 0 0 0 0 0 0 0
Totale 1.409